Disclosures for "IVIG Effective in Non-Length Dependent Skin Biopsies in Small Fiber Neuropathy with Plexin D1, TS-HDS, and FGFR-3 Antibodies"
-
Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. Dr. Zeidman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Swanson, Martin & Bell, LLP. The institution of Dr. Zeidman has received research support from Octapharma. Dr. Zeidman has received publishing royalties from a publication relating to health care.